Koutaro Yamaji1,2, Keita Kai3, Sho Komukai4, Hiroki Koga1, Takao Ide1, Atsushi Kawaguchi5, Hirokazu Noshiro1, Shinichi Aishima2,3. 1. Department of Surgery, Saga University Faculty of Medicine, Saga 849-8501, Japan. 2. Department of Pathology & Microbiology, Saga University Faculty of Medicine, Saga 849-8501, Japan. 3. Department of Pathology, Saga University Hospital, Saga 849-8501, Japan. 4. Clinical Research Center, Saga University Hospital, Saga 849-8501, Japan. 5. Center for Comprehensive Community Medicine, Saga University Faculty of Medicine, Saga 849-8501, Japan.
Abstract
BACKGROUND: We sought to clarify the prevalence of occult hepatitis B virus (HBV) infection (OBI) and to determine whether OBI affects the surgical outcomes in curatively resected Japanese patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC). METHODS: A total of 257 patients with HCV-related HCC who underwent curative surgical resection were enrolled. All enrolled patients were serologically negative for HBV surface antigen and positive for HCV antibody. DNA was extracted from formalin-fixed paraffin-embedded liver tissue. OBI was determined by the HBV-DNA amplification of at least two different sets of primers by TaqMan real-time polymerase chain reaction. Surgical outcomes were evaluated according to overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS). RESULTS: OBI was identified in 15 of the 257 (5.8%) cases. In the multivariate analyses, the factors significantly correlated with OS were BMI >25 (P=0.0416), portal vein invasion (P=0.0065), and multiple tumors (P=0.0064). The only factor significantly correlated with DSS was T-stage (P=0.0275). The factors significantly correlated with DFS were liver fibrosis (P=0.0017) and T-stage (P=0.0001). The status of OBI did not show any significant correlation with OS, DSS or DFS, but a weak association with DSS (P=0.0603) was observed. CONCLUSIONS: The prevalence of OBI was 5.8% in 257 cases of HCV-related HCC. Although a weak association between DSS and OBI was observed, and statistical analyses were limited by small number of OBI cases, no significant correlation between OBI and surgical outcomes was detected.
BACKGROUND: We sought to clarify the prevalence of occult hepatitis B virus (HBV) infection (OBI) and to determine whether OBI affects the surgical outcomes in curatively resected Japanese patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC). METHODS: A total of 257 patients with HCV-related HCC who underwent curative surgical resection were enrolled. All enrolled patients were serologically negative for HBV surface antigen and positive for HCV antibody. DNA was extracted from formalin-fixed paraffin-embedded liver tissue. OBI was determined by the HBV-DNA amplification of at least two different sets of primers by TaqMan real-time polymerase chain reaction. Surgical outcomes were evaluated according to overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS). RESULTS: OBI was identified in 15 of the 257 (5.8%) cases. In the multivariate analyses, the factors significantly correlated with OS were BMI >25 (P=0.0416), portal vein invasion (P=0.0065), and multiple tumors (P=0.0064). The only factor significantly correlated with DSS was T-stage (P=0.0275). The factors significantly correlated with DFS were liver fibrosis (P=0.0017) and T-stage (P=0.0001). The status of OBI did not show any significant correlation with OS, DSS or DFS, but a weak association with DSS (P=0.0603) was observed. CONCLUSIONS: The prevalence of OBI was 5.8% in 257 cases of HCV-related HCC. Although a weak association between DSS and OBI was observed, and statistical analyses were limited by small number of OBI cases, no significant correlation between OBI and surgical outcomes was detected.
Entities:
Keywords:
Occult hepatitis B virus infection (OBI); hepatitis C virus (HCV); hepatocellular carcinoma (HCC); prognosis; surgery
Authors: N De Maria; A Colantoni; L Friedlander; G Leandro; R Idilman; J Harig; D H Van Thiel Journal: Am J Gastroenterol Date: 2000-12 Impact factor: 10.864
Authors: E Sagnelli; N Coppola; C Scolastico; P Filippini; T Santantonio; T Stroffolini; F Piccinino Journal: Hepatology Date: 2000-11 Impact factor: 17.425
Authors: R Fukuda; N Ishimura; M Niigaki; S Hamamoto; S Satoh; S Tanaka; Y Kushiyama; Y Uchida; S Ihihara; S Akagi; M Watanabe; Y Kinoshita Journal: J Med Virol Date: 1999-07 Impact factor: 2.327
Authors: Mario Dinis-Ribeiro; Fernando Ramalho; Helena Glória; Rui Marinho; Miguel Raimundo; Fátima Serejo; José Velosa; Miguel Carneiro-de-Moura Journal: Hepatogastroenterology Date: 2005 Jan-Feb
Authors: Michael Torbenson; Rajesh Kannangai; Jacquie Astemborski; Steffanie A Strathdee; David Vlahov; David L Thomas Journal: Hepatology Date: 2004-01 Impact factor: 17.425